Professional Documents
Culture Documents
Gait Problems in Parkinsonism and Frontal Lobe Gait Disorders - Original.1538514874
Gait Problems in Parkinsonism and Frontal Lobe Gait Disorders - Original.1538514874
Simon JG Lewis, MD
Brain and Mind Centre, University of Sydney
The assessment of gait is of critical importance for every neurologist and is of particular
relevance in the evaluation of patients in the Movement Disorders setting. Important clues
and diagnostic insights are offered to the keen-eyed observer from the instant that the patient
is collected from the waiting room and relate to far more than just an appreciation of the gait
itself. This overview will offer insights into the critical neuroanatomy underpinning
locomotion, the key changes that can be observed in gait parameters across a range of
parkinsonian and related disorders, as well as highlighting some of the important associated
clinical features that can help to refine diagnostic accuracy and direct therapeutic
management.
Whilst the exact details of the neural processes underlying these connections are not fully
understood, it is thought that there are a number of ‘top-down’ influences that can impact
upon the relatively automatic neural reflexes of the spinal cord known as the Central Pattern
Generators. In addition, much interest has concentrated in the medulla and pons of the
brainstem where potential movement patterns may be more easily manipulated in response to
behavioural contingencies. For example, the mesencephalic locomotor region (MLR) of the
brainstem is thought to be mainly involved in the production of movement, whereas the
dorsal pedunculopontine nucleus (PPNd) is associated with the abrupt cessation of
movement. The basal ganglia nuclei are ideally placed to influence these regions by offering
flexibility in response to changing environmental contingencies. At rest, the main output
structures (the globus pallidus internus (GPi) and the substantia nigra pars reticularis (SNr))
provide tonic GABAergic inhibitory tone over the brainstem structures that control gait (such
as the MLR and PPNd) as well as the motor thalamus, effectively constraining information
flow in the spinal cord and cortex, respectively. During activity, cortical input to the basal
ganglia can either relieve (via the striatum) or facilitate (via the subthalamic nucleus; STN)
this inhibitory output. Whilst this allows flexible and volitional control over motor outputs it
Interestingly, recent work objectively comparing the long established clinical PD phenotypes
of tremor dominant versus postural instability with gait disturbance has demonstrated that
significant overlap exists between many parameters of gait and balance, casting serious doubt
on the clinical utility of this simplistic classification scheme4. Furthermore, there is a growing
appreciation that gait disturbances might represent a subtle ‘pre-clinical’ feature that could
assist in the prediction of those patients with idiopathic Rapid Eye Movement Sleep Behavior
Disorder (iRBD) who are most likely to transition to a neurodegenerative synucleinopathy.
Recent work evaluating gait parameters in iRBD has identified decreased velocity and
cadence, as well as significantly increased double limb support variability and greater
stride/swing time variability compared to age matched controls5. As yet, prospective follow
up data is not available to determine the clinical utility of these observations but home
activity monitoring devices have revealed that incident PD patients are significantly less
active than controls6, highlighting the importance that even subtle gait disturbances should be
targeted early by rehabilitation strategies.
The diagnosis of parkinsonian mimics like MSA, PSP and CBS from PD can be clearly very
challenging, especially at the time of the initial presentation. It is well known that many of
the ‘defining’ clinical features of these conditions emerge later in the disease course and
sometimes remain absent. Whilst specific diagnoses may be clinically defined, there is
significant heterogeneity even within recognised disease entities such as the Parkinsonian
(MSA-P), Cerebellar (MSA-C) and Autonomic (MSA-A) variants of MSA or the Pure
Akinesia and Gait Freezing (PAGF) variant of PSP. Attempts to use kinematic gait studies to
distinguish between these parkinsonian conditions have been hampered by the lack of direct
group comparisons and clinicopathological confirmation8. Indeed, recent work has shown
Conclusion
An appreciation of the clinical features associated with parkinsonian and HLGD in relation to
their underlying neuroanatomy can help the clinician with diagnosis, prognosis and
management of these challenging cases.
Simon Lewis
Professor of Cognitive Neuroscience
1
27/07/2018
• Neurological disease
– Multiple levels of pathology
– Can be concomitant
• Cortex
• Striatum
• Brainstem
• Cord
• Peripheral (nerves, vestibular, muscle)
Locomotor pathways
2
27/07/2018
Bipedal Locomotion
• Highly complex
– Balance
– Movement
– Goal directed and automatic
• Integrated systems
– Multiple levels
• Complexity
– Second only to language
– Walk and TALK!
Bipedal locomotion
• Cortico-basal ganglia
– Voluntary and cognitive control processes
• Basal ganglia-brainstem system
– Automatic control of movement
• Muscle tone system and locomotor system
– Balance between net excitatory cortical input and
inhibitory basal ganglia input
• Sensory integration
– Proprioception/Visuomotor/Cerebellar/Vestibular
3
27/07/2018
Decerebrate locomotion
• MLR and PPN
– Activate the locomotor central pattern
generator (CPG) in the spinal cord
• Automatic processes
– Activation of basic motor programs
– Motor repertoires
Decerebrate locomotion
4
27/07/2018
Decerebrate locomotion
5
27/07/2018
Early PD
6
27/07/2018
Transition to Synucleinopathy
• Schenck et al1
– 29 older men with iRBD
– 10 year follow up
– 38% transitioned to parkinsonian disorder
Transition to Synucleinopathy
7
27/07/2018
Transition to Synucleinopathy
• Iranzo et al 2013
– 14 year follow up period
• 36/44 participants (82%)
– Neurodegenerative syndrome
• Diagnosis
– 16 PD
– 14 LBD
– 1 MSA
– 5 MCI
Iranzo et al. (2013) Lancet Neurology
Transition to Synucleinopathy
8
27/07/2018
• iRDB v Controls
– Decreased velocity and cadence
– Increased double limb support variability
– Greater stride/swing time variability
• No longitudinal follow up
– Relationship to transition remains unknown
9
27/07/2018
Gait Abnormalities in
Early and Incident PD
• Subjective complaints rare and often
compensated (faster shorter steps)
• Dual-tasking: “early (<5 y)”1
– ↑ stride width & number of cadences
– ↓ swing/cycle time
• Dual-tasking and Home Monitoring: “incident”
– Only ↑ step width variability on dual-tasking2
– Less active - inability to sustain levels of walking3
1 Panyakaew & Bhidayasiri. Journal of Neural Transmission 2013
2 Rochester et al. Neuroscience 2014. 3 Lord et al. J Neurol 2014
Gait Abnormalities in PD
• Nigrostriatal loss correlated with bradykinesia
– However, dopamine does not restore normal gait
• Motor phenotype
– No clear gait relationship differences between
PIGD and Tremor Dominant PD1
• Comorbid cortical cholinergic dennervation
– More robust marker of slowing of gait in PD than
nigrostriatal dennervation alone2
10
27/07/2018
Advanced PD
Advanced PD
11
27/07/2018
Freezing of Gait
• Paroxysmal episodes of gait arrest
• Over 50% with advanced disease
• Limited therapeutic response
• Triggers/Relievers
– Turning
– Dual Tasking
– Doorways
– Cueing
Disease Stage
• H&Y Stage
12
27/07/2018
Start Hesitation
Turn
13
27/07/2018
Turn
Dual Task
14
27/07/2018
Doorway
Cueing
15
27/07/2018
DLB parkinsonism
16
27/07/2018
17
27/07/2018
DLB Luria
DLB Dyspraxia
18
27/07/2018
DLB Visuospatial
19
27/07/2018
MSA Gait
MSA
20
27/07/2018
Dysarthria
Eyes
21
27/07/2018
PSP Gait
22
27/07/2018
PSP Eyes
23
27/07/2018
PSP Grasp
PSP Dyspraxia
24
27/07/2018
25
27/07/2018
26
27/07/2018
CBS Gait
27
27/07/2018
CBS
CBS Dyspraxia
28
27/07/2018
29
27/07/2018
NPH
30
27/07/2018
Normal Pressure
Hydrocephalus
Normal Pressure
Hydrocephalus
• Shuffling Gait
– Parkinsonian
• Cognitive decline
– Frontal, dysexecutive
• Urinary Incontinence
31
27/07/2018
32
27/07/2018
Gait Disorders
• Red flags
– Early falls
– Associated signs/symptoms (cognition, bladder)
• Upper limbs
– ‘In’ or ‘Out’
– Posture
• Additional signs
– Higher order
– Eye movements
33
27/07/2018
Simon Lewis
Professor of Cognitive Neuroscience
1
27/07/2018
• Neurological disease
– Multiple levels of pathology
– Can be concomitant
• Cortex
• Striatum
• Brainstem
• Cord
• Peripheral (nerves, vestibular, muscle)
Locomotor pathways
2
27/07/2018
Bipedal Locomotion
• Highly complex
– Balance
– Movement
– Goal directed and automatic
• Integrated systems
– Multiple levels
• Complexity
– Second only to language
– Walk and TALK!
Bipedal locomotion
• Cortico-basal ganglia
– Voluntary and cognitive control processes
• Basal ganglia-brainstem system
– Automatic control of movement
• Muscle tone system and locomotor system
– Balance between net excitatory cortical input and
inhibitory basal ganglia input
• Sensory integration
– Proprioception/Visuomotor/Cerebellar/Vestibular
3
27/07/2018
Decerebrate locomotion
• MLR and PPN
– Activate the locomotor central pattern
generator (CPG) in the spinal cord
• Automatic processes
– Activation of basic motor programs
– Motor repertoires
Decerebrate locomotion
4
27/07/2018
Decerebrate locomotion
5
27/07/2018
Early PD
6
27/07/2018
Transition to Synucleinopathy
• Schenck et al1
– 29 older men with iRBD
– 10 year follow up
– 38% transitioned to parkinsonian disorder
Transition to Synucleinopathy
7
27/07/2018
Transition to Synucleinopathy
• Iranzo et al 2013
– 14 year follow up period
• 36/44 participants (82%)
– Neurodegenerative syndrome
• Diagnosis
– 16 PD
– 14 LBD
– 1 MSA
– 5 MCI
Iranzo et al. (2013) Lancet Neurology
Transition to Synucleinopathy
8
27/07/2018
• iRDB v Controls
– Decreased velocity and cadence
– Increased double limb support variability
– Greater stride/swing time variability
• No longitudinal follow up
– Relationship to transition remains unknown
9
27/07/2018
Gait Abnormalities in
Early and Incident PD
• Subjective complaints rare and often
compensated (faster shorter steps)
• Dual-tasking: “early (<5 y)”1
– ↑ stride width & number of cadences
– ↓ swing/cycle time
• Dual-tasking and Home Monitoring: “incident”
– Only ↑ step width variability on dual-tasking2
– Less active - inability to sustain levels of walking3
1 Panyakaew & Bhidayasiri. Journal of Neural Transmission 2013
2 Rochester et al. Neuroscience 2014. 3 Lord et al. J Neurol 2014
Gait Abnormalities in PD
• Nigrostriatal loss correlated with bradykinesia
– However, dopamine does not restore normal gait
• Motor phenotype
– No clear gait relationship differences between
PIGD and Tremor Dominant PD1
• Comorbid cortical cholinergic dennervation
– More robust marker of slowing of gait in PD than
nigrostriatal dennervation alone2
10
27/07/2018
Advanced PD
Advanced PD
11
27/07/2018
Freezing of Gait
• Paroxysmal episodes of gait arrest
• Over 50% with advanced disease
• Limited therapeutic response
• Triggers/Relievers
– Turning
– Dual Tasking
– Doorways
– Cueing
Disease Stage
• H&Y Stage
12
27/07/2018
Start Hesitation
Turn
13
27/07/2018
Turn
Dual Task
14
27/07/2018
Doorway
Cueing
15
27/07/2018
DLB parkinsonism
16
27/07/2018
17
27/07/2018
DLB Luria
DLB Dyspraxia
18
27/07/2018
DLB Visuospatial
19
27/07/2018
MSA Gait
MSA
20
27/07/2018
Dysarthria
Eyes
21
27/07/2018
PSP Gait
22
27/07/2018
PSP Eyes
23
27/07/2018
PSP Grasp
PSP Dyspraxia
24
27/07/2018
25
27/07/2018
26
27/07/2018
CBS Gait
27
27/07/2018
CBS
CBS Dyspraxia
28
27/07/2018
29
27/07/2018
NPH
30
27/07/2018
Normal Pressure
Hydrocephalus
Normal Pressure
Hydrocephalus
• Shuffling Gait
– Parkinsonian
• Cognitive decline
– Frontal, dysexecutive
• Urinary Incontinence
31
27/07/2018
32
27/07/2018
Gait Disorders
• Red flags
– Early falls
– Associated signs/symptoms (cognition, bladder)
• Upper limbs
– ‘In’ or ‘Out’
– Posture
• Additional signs
– Higher order
– Eye movements
33